A Point Mutation in the Groove of HLA-DO Allows Egress from the Endoplasmic Reticulum Independent of HLA-DM
B lymphocytes express the nonclassical class II molecule HLA-DO, which modulates the peptide loading activity of HLA-DM in the endocytic pathway. Binding to HLA-DM is required for HLA-DO to egress from the endoplasmic reticulum (ER). To gain insights into the mode of action of DO and on the role of...
Saved in:
Published in | Proceedings of the National Academy of Sciences - PNAS Vol. 102; no. 18; pp. 6443 - 6448 |
---|---|
Main Authors | , , , , , , |
Format | Journal Article |
Language | English |
Published |
United States
National Academy of Sciences
03.05.2005
National Acad Sciences |
Subjects | |
Online Access | Get full text |
Cover
Loading…
Summary: | B lymphocytes express the nonclassical class II molecule HLA-DO, which modulates the peptide loading activity of HLA-DM in the endocytic pathway. Binding to HLA-DM is required for HLA-DO to egress from the endoplasmic reticulum (ER). To gain insights into the mode of action of DO and on the role of DM in ER release, we sought to identify DM-binding residues on DO. Our results show that DOα encompasses the binding site for HLA-DM. More specifically, mutation of residue DOα41 on an exposed lateral loop of the α1 domain affects the binding to DM, ER egress, and activity of DO. Using a series of chimeric DR/DO molecules, we confirmed the role of the α chain and established that a second DM-binding region is located C-terminal to the DOα80 residue, most probably in the α2 domain. Interestingly, after mutation of a buried proline (α11) on the floor of the putative peptide-binding groove, HLA-DO remained functional but became independent of HLA-DM for ER egress and intracellular trafficking. Collectively, these results suggest that the binding of HLA-DM to DOα allows the complex to egress from the ER by stabilizing intramolecular contacts between the N-terminal antiparallel β-strands of the DOαβ heterodimer. |
---|---|
Bibliography: | ObjectType-Article-2 SourceType-Scholarly Journals-1 ObjectType-Feature-1 content type line 23 To whom correspondence may be addressed. E-mail: jacques.thibodeau@umontreal.ca or asamaan@pasteur.fr. Author contributions: F.D., A.B., A.S., and J.T. designed research; F.D., A.B., and D.A.D. performed research; L.K.D. and A.S. contributed new reagents/analytic tools; F.D., A.B., D.A.D., L.K.D., and J.T. analyzed data; and F.D., A.B., L.K.D., A.S., and J.T. wrote the paper. Abbreviations: ER, endoplasmic reticulum; Ii, invariant chain; CLIP, class II-associated Ii peptide; CIITA, class II transactivator; cDO, chimeric DO. This paper was submitted directly (Track II) to the PNAS office. Edited by Peter Cresswell, Yale University School of Medicine, New Haven, CT, and approved March 17, 2005 |
ISSN: | 0027-8424 1091-6490 |
DOI: | 10.1073/pnas.0500853102 |